MedPath
TGA Approval

BUVIDAL MONTHLY buprenorphine 160 mg/0.45 mL modified release solution for injection (341073)

341073

BUVIDAL MONTHLY buprenorphine 160 mg/0.45 mL modified release solution for injection

Camurus Pty Ltd

April 30, 2021

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/a2e4365907a1b8ef072ff080ddd7fef6.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/8b2a7f3c41e7cdc66dcdeab7420aae51.pdf

Active Ingredients

buprenorphine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BUVIDAL MONTHLY buprenorphine 160 mg/0.45 mL modified release solution for injection (341073) - TGA 批准文号 | MedPath